BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 11095429)

  • 21. Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot.
    de Brito VN; Latronico AC; Arnhold IJ; Lo LS; Domenice S; Albano MC; Fragoso MC; Mendonca BB
    Arch Dis Child; 1999 Mar; 80(3):231-4. PubMed ID: 10325702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of body mass index on luteinizing hormone secretion in gonadotropin-releasing hormone stimulation tests of boys experiencing precocious puberty.
    Lee HS; Park HK; Ko JH; Kim YJ; Hwang JS
    Neuroendocrinology; 2013; 97(3):225-31. PubMed ID: 22907516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.
    Bertelloni S; Baroncelli GI; Ferdeghini M; Menchini-Fabris F; Saggese G
    Eur J Pediatr; 2000 May; 159(5):369-74. PubMed ID: 10834524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of deslorelin dose in the treatment of central precocious puberty.
    Pescovitz OH; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precocious puberty in children with tumours of the suprasellar and pineal areas: organic central precocious puberty.
    Rivarola ; Belgorosky A; Mendilaharzu H; Vidal G
    Acta Paediatr; 2001 Jul; 90(7):751-6. PubMed ID: 11519977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history.
    Mahachoklertwattana P; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1993 Jul; 77(1):118-24. PubMed ID: 8325933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamo-pituitary-gonadal function in male central precocious puberty.
    Chaussain JL; Savage MO; Nahoul K; Brijawi A; Canlorbe P; Job JC
    Clin Endocrinol (Oxf); 1978 Jun; 8(6):437-44. PubMed ID: 352578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.
    Laue L; Jones J; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1993 Jan; 76(1):151-5. PubMed ID: 8421081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precocious puberty due to a hypothalamic hamartoma.
    Takeuchi J; Handa H; Miki Y; Munemitsu H; Aso T
    Surg Neurol; 1979 Jun; 11(6):456-60. PubMed ID: 384570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons.
    Jung H; Carmel P; Schwartz MS; Witkin JW; Bentele KH; Westphal M; Piatt JH; Costa ME; Cornea A; Ma YJ; Ojeda SR
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4695-701. PubMed ID: 10599738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.
    Andersson AM; Juul A; Petersen JH; Müller J; Groome NP; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3976-81. PubMed ID: 9398699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test.
    Ibáñez L; Potau N; Zampolli M; Virdis R; Gussinyé M; Carrascosa A; Saenger P; Vicens-Calvet E
    J Clin Endocrinol Metab; 1994 Jan; 78(1):30-5. PubMed ID: 7507123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
    Comite F; Cassorla F; Barnes KM; Hench KD; Dwyer A; Skerda MC; Loriaux DL; Cutler GB; Pescovitz OH
    JAMA; 1986 May; 255(19):2613-6. PubMed ID: 3084811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.
    Lahlou N; Roger M; Chaussain JL; Feinstein MC; Sultan C; Toublanc JE; Schally AV; Scholler R
    J Clin Endocrinol Metab; 1987 Nov; 65(5):946-53. PubMed ID: 2959680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study.
    Ghai K; Cara JF; Rosenfield RL
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2980-6. PubMed ID: 7559884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothalamic hamartoma with precocious puberty: a case report.
    Amin MS; Kader MA; Huq FI; Khan NA
    Mymensingh Med J; 2012 Jul; 21(3):553-6. PubMed ID: 22828561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central precocious puberty: clinical and laboratory features.
    Chemaitilly W; Trivin C; Adan L; Gall V; Sainte-Rose C; Brauner R
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):289-94. PubMed ID: 11298079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes.
    Latronico AC; Lins TS; Brito VN; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):609-13. PubMed ID: 11106922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.